Live from the NIH registry
Studies recruiting near Fort Collins right now
Top 25 of 159 recruiting studies, sorted by proximity — each links to its official registry page
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Smoldering Plasma Cell Myeloma
Phase 3
Interventional 288 participants sought
Banner North Colorado Medical Center - Loveland Campus — Loveland, Colorado (10.4 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT
Hypertension, Hypertension, Systolic
N/A
Interventional 316 participants sought
UCHealth Medical Center of the Rockies — Loveland, Colorado (10.4 mi)
· Sponsor: Orchestra BioMed, Inc
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
Non-Small Cell Lung Cancer, KRAS G12C Lung Cancer
Phase 3
Interventional 600 participants sought
Poudre Valley Health Care, Inc. d/b/a Poudre Valley Health System — Fort Collins, Colorado (2.8 mi)
· Sponsor: Hoffmann-La Roche
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
Head and Neck Squamous Cell Carcinoma, Hypopharyngeal Squamous Cell Carcinoma
Phase 2
Interventional 189 participants sought
Longmont United Hospital — Longmont, Colorado (26.4 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
Plasma Cell Myeloma
Phase 3
Interventional 510 participants sought
Longmont United Hospital — Longmont, Colorado (26.4 mi)
· Sponsor: SWOG Cancer Research Network
Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma
Classic Follicular Lymphoma, Follicular Lymphoma With Unusual Cytological Features
Phase 3
Interventional 600 participants sought
Poudre Valley Hospital — Fort Collins, Colorado (2.8 mi)
· Sponsor: National Cancer Institute (NCI)
Collection of Research Data and Samples From Patients Who Experience Immunotherapy Side Effects
Malignancy
N/A
Observational 240 participants sought
Longmont United Hospital — Longmont, Colorado (26.4 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
A Study to Assess Adverse Events and Effectiveness of Gel Stent (XEN63) Implantation Using Ab Interno and Ab Externo Approaches in Adult Participants With Glaucoma
Primary Open Angle Glaucoma
Phase 3
Interventional 130 participants sought
Eye Center of Northern Colorado /ID# 281798 — Fort Collins, Colorado (2.8 mi)
· Sponsor: AbbVie
A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)
Colon Adenocarcinoma, Rectal Adenocarcinoma
Phase 3
Interventional 477 participants sought
University of Colorado Health - Harmony-Cancer Care and Hematology - Ft. Collins ( Site 0087) — Fort Collins, Colorado (2.8 mi)
· Sponsor: Merck Sharp & Dohme LLC
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
Advanced Endometrial Carcinoma, Recurrent Endometrial Carcinoma
Phase 3
Interventional 255 participants sought
Poudre Valley Hospital — Fort Collins, Colorado (2.8 mi)
· Sponsor: National Cancer Institute (NCI)
Improving Care for Rural Patients With Solid Tumors
Lung Cancer, Head and Neck Cancer
N/A
Interventional 320 participants sought
Poudre Valley Hospital — Fort Collins, Colorado (2.8 mi)
· Sponsor: University of Colorado, Denver
A Phase 2, Randomized, Placebo Controlled, Multicenter, Masked Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Multidose APL 3007 in Combination With Syfovre/Pegcetacoplan (APL-2) in Patients Diagnosed With Geographic Atrophy Secondary to Age Related Macular Degeneratio
Geographic Atrophy Secondary to Age-related Macular Degeneration
Phase 2
Interventional 240 participants sought
Advanced Vision Research Institute — Longmont, Colorado (26.4 mi)
· Sponsor: Apellis Pharmaceuticals, Inc.
Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)
Generalized Myasthenia Gravis
N/A
Observational 500 participants sought
Clinical Trial Site — Fort Collins, Colorado (2.8 mi)
· Sponsor: Alexion Pharmaceuticals, Inc.
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
B-cell Malignancy, Marginal Zone Lymphoma
Phase 1, Phase 2
Interventional 645 participants sought
Uchealth North — Fort Collins, Colorado (2.8 mi)
· Sponsor: BeOne Medicines
Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors
Colorectal Cancer Stage II, Colorectal Cancer Stage III
Phase 3
Interventional 1,057 participants sought
Longmont United Hospital — Longmont, Colorado (26.4 mi)
· Sponsor: SWOG Cancer Research Network
A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other Treatments
Multiple Myeloma
Phase 3
Interventional 893 participants sought
UCHealth Poudre Valley Hospital — Fort Collins, Colorado (2.8 mi)
· Sponsor: Pfizer
Efficacy and Safety of IMVT-1402 in Adult Participants With Primary Sjogren's Disease With Moderate to Severe Systemic Disease Activity
Primary Sjögren's Syndrome
Phase 2
Interventional 180 participants sought
Site Number - 1014 — Fort Collins, Colorado (2.8 mi)
· Sponsor: Immunovant Sciences GmbH
A Study of Ocrelizumab Administered Subcutaneously in Participants With Multiple Sclerosis Who Switch From an Approved Anti-CD20 Therapy
Multiple Sclerosis
Phase 4
Interventional 100 participants sought
Advanced Neurology of Colorado — Fort Collins, Colorado (2.8 mi)
· Sponsor: Genentech, Inc.
A Phase Ⅲ Clinical Study of HLX22 in Combination With Trastuzumab and Chemotherapy for the Treatment of Gastroesophageal Junction and Gastric Cancer
Gastroesophageal-junction Cancer, Monoclonal Antibody
Phase 3
Interventional 550 participants sought
Banner MD Anderson Cancer Center — Greeley, Colorado (20.6 mi)
· Sponsor: Shanghai Henlius Biotech
A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)
Carcinoma, Non-Small-Cell Lung
Phase 3
Interventional 680 participants sought
Banner MD Anderson Cancer Center at North Colorado Medical Center ( Site 0207) — Greeley, Colorado (20.6 mi)
· Sponsor: Merck Sharp & Dohme LLC
Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer
Oropharyngeal p16INK4a-Negative Squamous Cell Carcinoma, Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7
Phase 2, Phase 3
Interventional 613 participants sought
Banner North Colorado Medical Center - Loveland Campus — Loveland, Colorado (10.4 mi)
· Sponsor: National Cancer Institute (NCI)
PARTNER 3 Trial - Aortic Valve-in-Valve
Aortic Stenosis, Aortic Stenosis, Severe
N/A
Interventional 125 participants sought
UC Health Northern Colorado/Medical Center of the Rockies — Loveland, Colorado (10.4 mi)
· Sponsor: Edwards Lifesciences
Elranatamab Post Trial Access Study for Participants With Multiple Myeloma (MM)
Multiple Myeloma
Phase 4
Interventional 80 participants sought
UCHealth Poudre Valley Hospital — Fort Collins, Colorado (2.8 mi)
· Sponsor: Pfizer
Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations
Locally Advanced Pancreatic Adenocarcinoma, Metastatic Pancreatic Adenocarcinoma
Phase 3
Interventional 94 participants sought
Longmont United Hospital — Longmont, Colorado (26.4 mi)
· Sponsor: SWOG Cancer Research Network
Biospecimen and Medical Data Collection and Tumor Biopsy in Creating Research Tissue Registry in Patients With Inflammatory or Invasive Breast Cancer
Inflammatory Breast Carcinoma, Invasive Breast Carcinoma
N/A
Observational 1,200 participants sought
Banner - MD Anderson Cancer Center - Northern Colorado — Greeley, Colorado (20.6 mi)
· Sponsor: M.D. Anderson Cancer Center